Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...
The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...
After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...
The Chinese government listed Illumina, whose global headquarters is in California, as an “unreliable entity” shortly after ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...
Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...
For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...
The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results